Citigroup Inc Simulations Plus, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Simulations Plus, Inc. stock. As of the latest transaction made, Citigroup Inc holds 23,508 shares of SLP stock, worth $806,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,508

Previous 15,725 49.49%

Holding current value

$806,794

Previous $764,000 1.57%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$30.46 - $46.86 $237,070 - $364,711	7,783 Added 49.49%	23,508 $752,000
Q2 2024 Aug 12, 2024	BUY	$38.46 - $50.95 $36,613 - $48,504	952 Added 6.44%	15,725 $764,000
Q1 2024 May 10, 2024	BUY	$37.48 - $44.74 $105,731 - $126,211	2,821 Added 23.6%	14,773 $607,000
Q4 2023 Feb 09, 2024	BUY	$33.36 - $45.71 $154,156 - $211,225	4,621 Added 63.03%	11,952 $534,000
Q3 2023 Nov 09, 2023	SELL	$40.03 - $51.51 $256,312 - $329,818	-6,403 Reduced 46.62%	7,331 $305,000
Q2 2023 Aug 10, 2023	BUY	$40.45 - $48.0 $197,881 - $234,816	4,892 Added 55.33%	13,734 $595,000
Q1 2023 May 11, 2023	SELL	$34.96 - $43.94 $62,438 - $78,476	-1,786 Reduced 16.8%	8,842 $388,000
Q4 2022 Feb 09, 2023	BUY	$36.55 - $51.15 $95,687 - $133,910	2,618 Added 32.68%	10,628 $388,000
Q3 2022 Nov 10, 2022	BUY	$47.75 - $66.88 $34,141 - $47,819	715 Added 9.8%	8,010 $389,000
Q2 2022 Aug 10, 2022	SELL	$40.55 - $51.76 $264,629 - $337,785	-6,526 Reduced 47.22%	7,295 $360,000
Q1 2022 May 12, 2022	BUY	$36.56 - $50.98 $65,990 - $92,018	1,805 Added 15.02%	13,821 $705,000
Q4 2021 Feb 10, 2022	BUY	$37.1 - $57.45 $137,715 - $213,254	3,712 Added 44.7%	12,016 $568,000
Q3 2021 Nov 10, 2021	BUY	$38.45 - $55.66 $319,288 - $462,200	8,304 New	8,304 $328,000

Others Institutions Holding SLP

# of Institutions

170

Shares Held

15.5M

Call Options Held

5.4K

Put Options Held

1.4K

View Full List

About Simulations Plus, Inc.

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $697M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

More about SLP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account